Sign In
Buy DHR
$178.08
+1.97 (+1.12%)
At Close: Jun 03, 2026
8 Upcoming Dividend Increases, Including A King
05:06pm, Monday, 24'th Mar 2025
Highlighting eight companies with upcoming dividend increases, four exceeding 10%, and an average increase of 11.4%, median at 9%. My investment strategy focuses on buying, holding, and expanding stak
Danaher: Near 5-Year Low Is A Great Entry Point
08:00am, Saturday, 22'nd Mar 2025
Danaher Corporation is trading near its 5-year low, presenting a potential buying opportunity for growth investors despite near-term headwinds. DHR's strong fundamentals include leadership in biotechn
Danaher Schedules First Quarter 2025 Earnings Conference Call
04:15pm, Thursday, 20'th Mar 2025
WASHINGTON , March 20, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2025 on Tuesday, April 22, 2025
Here's Why You Should Avoid Betting on Danaher Stock Right Now
12:40pm, Tuesday, 11'th Mar 2025
Persistent softness in the Life Sciences segment weighs on DHR's performance. An increase in operating expenses is an added concern.
Beckman Coulter Announces FDA clearance of DxC 500i Clinical Analyzer, an integrated Clinical Chemistry and Immunoassay System
08:30am, Monday, 10'th Mar 2025
The new DxC 500i Analyzer Offers Flexibility and Scalability with Broad Chemistry and Immunoassay Assay Menu BREA, Calif. , March 10, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diag
Danaher Corporation (DHR) TD Cowen 45th Annual Health Care Conference Transcript
01:25pm, Wednesday, 05'th Mar 2025
Danaher Corporation (NYSE:DHR ) TD Cowen 45th Annual Health Care Conference Call March 5, 2025 10:30 AM ET Company Participants Rainer Blair – President and Chief Executive Officer Conference Call P
Danaher to Present at TD Cowen Health Care Conference
04:15pm, Tuesday, 25'th Feb 2025
WASHINGTON , Feb. 25, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the TD Cowen Healthcare Confere
Danaher Rewards Shareholders With 18.5% Dividend Increase
04:00pm, Monday, 24'th Feb 2025
DHR's measures to consistently reward shareholders through dividends and share buybacks hold promise.
An industrial laser marking machine uses laser technology to engrave, etch, or mark materials with precision for identification, branding, or tracking. An industrial laser marking machine uses laser t
3 Stocks Offering Strong Value and Stability
07:30am, Monday, 24'th Feb 2025
Though not as safe a bet as safe-haven assets like precious metals, value stocks are nonetheless an enticing option for investors when the market gets bumpy. An undervalued company that has excellen
Danaher Announces Appointment of Charles Lamanna to Danaher Board
04:45pm, Thursday, 20'th Feb 2025
WASHINGTON , Feb. 20, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it has appointed Charles Lamanna to its Board of Directors and to the Board's Science & Technology Commi
Danaher Increases Quarterly Dividend
04:15pm, Thursday, 20'th Feb 2025
WASHINGTON , Feb. 20, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common
Danaher: Self-Inflicted Pessimism?
01:46am, Monday, 17'th Feb 2025
Danaher Corp. has faced market punishment recently, but maintains strong margins and impressive FCF despite a tough year, indicating resilience and potential for future growth. The company's strategic
All-In: The 23-Stock Six-Figure Dividend Portfolio I'm Betting My Future On
07:30am, Friday, 14'th Feb 2025
Thank you to the Seeking Alpha community for your support! Reaching 40,000 followers is a dream come true. Your feedback fuels my work. I've invested 91% of my net worth in 23 high-conviction dividend
Molecular Infectious Disease Testing Market to Hit USD 17.78 Billion by 2029 with 13.7% CAGR | MarketsandMarkets™.
10:05am, Thursday, 13'th Feb 2025
DELRAY BEACH, Fla., Feb. 13, 2025 /PRNewswire/ -- The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, reaching U
